Modern aspects of disability due to eye diseases

Cover Page

Cite item


Despite current successes of ophthalmology, during the last decades, blindness and low vision affect the population of both developed and developing countries. In United States, the prevalence of blindness in 1940 was 17.5 per 10 thousand in 1960-1979, this figure reached 20.0, and nowadays - 50.0 per 10 thousand. population. According to the World Health Organization data of 2014, the World has 285 million blind and visually impaired people, 90% of visually impaired live in developing countries. The main causes of blindness in underdeveloped and developing countries are cataract, trachoma, onchocerciasis, xerophthalmia. In highly developed countries, the causes are different - glaucoma, degenerative myopia, cataract, chorioretinal degeneration, diabetic retinopathy, congenital eye diseases. In the Russian Federation, the prevalence of blindness and low vision, as well as the structure of nosologies leading to these conditions are similar to those in developed countries. The prevalence of blindness and low vision in Russia, according to E.S. Liebman, for the 1985-2002 increased from 13.6 to 17.0 per 10 thousand, and the prevalence of blindness - from 7.0 to 7.8 per 10 thousand. The maximum rates observed in the Central and Volga economic regions (25.6 and 20.3), in the Udmurt Republic (39.6), Lipetsk (41.1) and Yaroslavl (34.3) regions (per 10 thousand). The World Health Organization has developed a long-term plan of action for the prevention of eye diseases in the global initiative «Vision 2020: the Right to Sight». A good progress has been made, particularly in combating infectious causes of blindness by supporting the Member States and attracting long-term resources. Thus, an active work is ongoing to reduce the disability due to eye diseases worldwide. Up to 80% of cases of blindness can be avoided with early diagnosis and treatment of patients.

About the authors

M G Nazaryan

Federal Bureau for Medical and Social Expertise of Ministry of Labour and Social Affairs of Russian Federation, Moscow, Russia

Author for correspondence.

P M Arbukhanova

Intersectional Science & Technology Complex «Eye Microsurgery» named after S.N. Fedorov, Moscow, Russia



  1. Гришина Л.П. Актуальные проблемы инвалидности в Российской Федерации. - М.: Академический проект, 1995. - 203 с.
  2. Либман Е.С. Современные позиции клинико-социальной офтальмологии // Вестн. офтальмол. - 2004. - Т. 120, №1. - С. 10-12.
  3. Лисицын Ю.П. Социальная гигиена и организация здравоохранения. - М.: Медицина, 1992. - 512 с.
  4. Лисицын Ю.П. Теории медицины XX века. - М.: Медицина, 1999. - 176 с.
  5. Нестеров В.А. Статистика инвалидности. - М.: Медицина, 1977. - 168 с.
  6. Профилактика предупреждаемой слепоты и нарушений зрения. Доклад секретариата ВОЗ. Документ ЕВ124/7. - Женева, 2008. - 20 с. -
  7. Профилактика предотвращаемых случаев слепоты и нарушений зрения. Резолюция ВОЗ. Документ WHA 59.25. - Женева, 2010. - 17 с.
  8. Foster A. Cataract and «Vision 2020 the right to sight» initiative // Br. J. Ophthalmol. - 2001. - N 85. - P. 635-637.
  9. Frick K.D., Foster A. The magnitude and cost of global blindness: an increasing problem that can be alleviated // Am. J. Ophthalmol. - 2003. - Vol. 4. - P. 471-476.
  10. Leonard R. Statistics on vision impairment: a resource manual 5ed. - N.Y.: Lighthouse Int., 2002. - 41 p.
  11. London School of Hygiene & Tropical Medicine. Annual report. - London, 2003. - 257 р.
  12. Roodhoft J.M.J. Leading causes of blindness worldwide // Bull. Soc. Beige. Ophthalmol. - 2002. - N 283. - P. 19-25.
  13. Sorsby A. The incidence and causes of blindness in England and Wales, 1948, 1952, 1966 // Reports on Public Health and Medical Subject: Her Majesty’s Stationary office. - 1966. - Vol. 79. - 26 p.
  14. Sommer A. Field guide to the detection and control of xerophthalmia. - Geneva: World Health Organization, 1978. - 48 p.

© 2015 Nazaryan M.G., Arbukhanova P.M.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies